A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational ...

The NHS’ long term survival is at stake – the Ten Year Plan demonstrates the government’s commitment to invest in its recovery, but in order to truly tackle the existential issues at the heart of the ...

This panel brings together leading researchers to explore how health economics can inform policy design in the context of the climate crisis. Rather than proposing new evaluative paradigms, the ...

Next-generation sequencing (NGS) generates comprehensive and actionable information on molecular tumour profiles. But despite recommendations for the use of NGS in lung cancer, and support for its ...

The purpose of this research is to identify the attributes to include in a value framework for orphan medicinal products (OMPs), determine their relative importance using a multi-criteria decision ...

This report contributes to the understanding of people’s proximity to dementia (e.g., people with dementia and their carers forecast) and so the potential future number of people who will be impacted ...

Real-World Evidence (RWE) can provide decision-makers in the healthcare sector with insights into the functioning of health technologies outside of clinical trial settings. In this report, we focus on ...

Most value assessments of vaccination programs are carried out by taking the perspective of the health system. To stimulate the debate concerning the broader value of vaccination beyond this ...

Our Board of Trustees and advisory committees are essential to guiding our work, maintaining the quality and independence of our research programme and our publications, and ensuring we align with our ...

Hidradenitis Suppurativa (HS) has a significant impact on the wellbeing of people living with the condition, the National Health Service (NHS), and broader society, but HS and its range of impacts are ...

In this report, we propose a novel payment model that will incentivise broader value demonstration for diagnostics for antibiotics that could inform longer-term financing and reimbursement ...

In this report, we describe the design of a globally aligned, value-based, fully-delinked pull incentive, where payers provide manufacturers with a pre-specified subscription fee based on the value of ...